ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma

Figure 3

(a) ARID1A expression and overall survival in liver cancer patients in TCGA cohort. (b) MultiCox analysis regression analysis identifying prognostic variables with HR with 95% CI and P values.

(a)

(b)